Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis

References

• Silberstein J, Tuchman S, Grant SJ. What is multiple Myeloma? JAMA. 2022;327(5):497. doi:10.1001/jama.2021.25306
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, L SR, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• K KS, Rajkumar V, A KR, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046. doi:10.1038/nrdp.2017.46
   PubMed Web of Science ®Google Scholar
• E JD, Bryant C, Dix C, et al. Biology and therapy of multiple myeloma. Med J Aust. 2019;210(8):375–380. doi:10.5694/mja2.50129
   PubMed Web of Science ®Google Scholar
• Ahmetlic F, Fauser J, Riedel T, et al. Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence. J Immunother Cancer. 2021;9(1):e001660. doi:10.1136/jitc-2020-001660
   PubMed Web of Science ®Google Scholar
• Wang D, Wang J, Hu G, et al. A Phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma. Blood. 2021;137(21):2890–2901. doi:10.1182/blood.2020008936
   PubMed Web of Science ®Google Scholar
• Quach H, Ritchie D, K SA, et al. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2010;24(1):22–32. doi:10.1038/leu.2009.236
   PubMed Web of Science ®Google Scholar
• Nahi H, Chrobok M, Meinke S, et al. Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma. Cell Rep Med. 2022;3(2):100508. doi:10.1016/j.xcrm.2022.100508
   PubMedGoogle Scholar
• Han Y, Wang Y, Dong X, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(D1):D1425–D1431. doi:10.1093/nar/gkac959
   PubMed Web of Science ®Google Scholar
• G FA, L M-B-B, Yu J, et al. The broad spectrum of human natural killer cell diversity. Immunity. 2017;47(5):820–833. doi:10.1016/j.immuni.2017.10.008
   PubMed Web of Science ®Google Scholar
• Y WS, Fu T, Z JY, et al. Natural killer cells in cancer biology and therapy. Mol Cancer. 2020;19(1):120. doi:10.1186/s12943-020-01238-x
   PubMed Web of Science ®Google Scholar
• Leivas A, Valeri A, Cordoba L, et al. NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma. Blood Cancer J. 2021;11(8):146. doi:10.1038/s41408-021-00537-w
   PubMed Web of Science ®Google Scholar
• Christodoulou I, J HW, Marple A, et al. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. J Immunother Cancer. 2021;9(12):e003894. doi:10.1136/jitc-2021-003894
   PubMed Web of Science ®Google Scholar
• Liao C, Wang Y, Huang Y, et al. CD38-Specific CAR Integrated into CD38 locus driven by different promoters causes distinct antitumor activities of T and NK cells. Adv Sci (Weinh). 2023;10(27):e2207394. doi:10.1002/advs.202207394
   PubMedGoogle Scholar
• Liu E, Marin D, Banerjee P, et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N Engl J Med. 2020;382(6):545–553. doi:10.1056/NEJMoa1910607
   PubMed Web of Science ®Google Scholar
• Li M, Huang J, Zhan G, et al. The novel-natural-killer-cell-related gene signature predicts the prognosis and immune status of patients with hepatocellular carcinoma. Int J Mol Sci. 2023;24(11):1.
   Web of Science ®Google Scholar
• Swamydas M, V ME, J I-HJ, et al. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. J Hematol Oncol. 2022;15(1):17. doi:10.1186/s13045-022-01234-2
   PubMed Web of Science ®Google Scholar
• Holthof LC, Mutis T. Challenges for immunotherapy in multiple myeloma: bone marrow microenvironment-mediated immune suppression and immune resistance. Cancers (Basel). 2020;12(4):988. doi:10.3390/cancers12040988
   PubMed Web of Science ®Google Scholar
• Fauriat C, Mallet F, Olive D, et al. Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma. Leukemia. 2006;20(4):732–733. doi:10.1038/sj.leu.2404096
   PubMed Web of Science ®Google Scholar
• Trezise S, Karnowski A, L FP, et al. Mining the plasma cell transcriptome for novel cell surface proteins. Int J Mol Sci. 2018;19(8):2161. doi:10.3390/ijms19082161
   PubMed Web of Science ®Google Scholar
• Chu F, Cao J, Liu J, et al. Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. J Immunother Cancer. 2023;11(11):e007515. doi:10.1136/jitc-2023-007515
   PubMed Web of Science ®Google Scholar
• J ZW, Liu Y, Guo J, et al. Prognostic biomarkers identification in esophageal cancer based on WGCNA and single-cell analysis. Dis Markers. 2022;2022:6595778. doi:10.1155/2022/6595778
   PubMedGoogle Scholar
• Xu X, Zhang C, Xia Y, et al. Over expression of METRN predicts poor clinical prognosis in colorectal cancer. Mol Genet Genomic Med. 2020;8(3):e1102. doi:10.1002/mgg3.1102
   PubMed Web of Science ®Google Scholar
• Meng X, Song W, Zhou B, et al. Prognostic and immune correlation analysis of mitochondrial autophagy and aging-related genes in lung adenocarcinoma. J Cancer Res Clin Oncol. 2023;149(18):16311–16335. doi:10.1007/s00432-023-05390-x
   PubMed Web of Science ®Google Scholar
• R LA, N LY, X SS, et al. Comprehensive analysis and validation of solute carrier family 25 (SLC25) and its correlation with immune infiltration in pan-cancer. Biomed Res Int. 2022;2022:4009354. doi:10.1155/2022/4009354
   PubMed Web of Science ®Google Scholar
• Ormonde J, Li Z, Stegen C, et al. TAOK3 regulates canonical TCR signaling by preventing early SHP-1-mediated inactivation of LCK. J Immunol. 2018;201(11):3431–3442. doi:10.4049/jimmunol.1800284
   PubMed Web of Science ®Google Scholar
• Vanderkerken M, Maes B, Vandersarren L, et al. TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells. Proc Natl Acad Sci U S A. 2020;117(49):31331–31342. doi:10.1073/pnas.2009847117
   PubMed Web of Science ®Google Scholar
• Shu L, Tang J, Liu S, et al. Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma. Cell Oncol Dordr. 2023;47:555–571. doi:10.1007/s13402-023-00883-w
   PubMed Web of Science ®Google Scholar
• Tabellini G, Baronio M, Patrizi O, et al. The RAC2-PI3K axis regulates human NK cell maturation and function. Clin Immunol. 2019;208:108257. doi:10.1016/j.clim.2019.108257
   PubMed Web of Science ®Google Scholar
• Wang D, Uyemura B, Hashemi E, et al. Role of GATA2 in Human NK Cell Development. Crit Rev Immunol. 2021;41(2):21–33. doi:10.1615/CritRevImmunol.2021037643
   PubMed Web of Science ®Google Scholar
• Sariman M, Abaci N, S SE, et al. Investigation of gene expressions of myeloma cells in the bone marrow of multiple myeloma patients by transcriptome analysis. Balkan Med J. 2019;36(1):23–31. doi:10.4274/balkanmedj.2018.0356
   PubMed Web of Science ®Google Scholar
• S MN, Kushwaha S, R VR, et al. Unlocking the Potential of the CA2, CA7, and ITM2C gene signatures for the early detection of colorectal cancer: a comprehensive analysis of RNA-Seq Data by utilizing machine learning algorithms. Genes (Basel). 2023;14(10). doi:10.3390/genes14101836
   Web of Science ®Google Scholar
• Xiao B, Hang J, Lei T, et al. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system. Mol Biol Rep. 2019;46(2):2111–2119. doi:10.1007/s11033-019-04663-4
   PubMed Web of Science ®Google Scholar
• Brennan K, F IK, Blanco-Fernandez A, et al. Extracellular vesicles isolated from plasma of multiple myeloma patients treated with daratumumab express CD38, PD-L1, and the complement inhibitory proteins CD55 and CD59. Cells. 2022;11(21):3365. doi:10.3390/cells11213365
   PubMed Web of Science ®Google Scholar
• Omidvar N, C WE, Brennan P, et al. Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity. J Immunol. 2006;176(5):2915–2923. doi:10.4049/jimmunol.176.5.2915
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang X, Li H, et al. Novel subsets of peripheral immune cells associated with promoting stroke recovery in mice. CNS Neurosci Ther. 2024;30(4):e14518. doi:10.1111/cns.14518
   PubMed Web of Science ®Google Scholar
• H MY, Yang Y, H LJ, et al. NDUFB11 and NDUFS3 regulate arterial atherosclerosis and venous thrombosis: potential markers of atherosclerosis and venous thrombosis. Medicine (Baltimore). 2023;102(46):e36133.
   PubMed Web of Science ®Google Scholar
• Strizova Z, Taborska P, Stakheev D, et al. NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma. Urol Oncol. 2019;37(7):503–509. doi:10.1016/j.urolonc.2019.03.014
   PubMed Web of Science ®Google Scholar
• Bai L, You Q, Feng X, et al. Structure of the ER membrane complex, a transmembrane-domain insertase. Nature. 2020;584(7821):475–478. doi:10.1038/s41586-020-2389-3
   PubMed Web of Science ®Google Scholar